Sökning: WFRF:(Berven F. S.) > Consensus definitio...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 03477naa a2200637 4500 | |
001 | oai:prod.swepub.kib.ki.se:127920274 | |
003 | SwePub | |
008 | 240701s2013 | |||||||||||000 ||eng| | |
024 | 7 | a http://kipublications.ki.se/Default.aspx?queryparsed=id:1279202742 URI |
024 | 7 | a https://doi.org/10.1177/13524585134882322 DOI |
040 | a (SwePub)ki | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Teunissen, C4 aut |
245 | 1 0 | a Consensus definitions and application guidelines for control groups in cerebrospinal fluid biomarker studies in multiple sclerosis |
264 | c 2013-05-21 | |
264 | 1 | b SAGE Publications,c 2013 |
520 | a The choice of appropriate control group(s) is critical in cerebrospinal fluid (CSF) biomarker research in multiple sclerosis (MS). There is a lack of definitions and nomenclature of different control groups and a rationalized application of different control groups. We here propose consensus definitions and nomenclature for the following groups: healthy controls (HCs), spinal anesthesia subjects (SASs), inflammatory neurological disease controls (INDCs), peripheral inflammatory neurological disease controls (PINDCs), non-inflammatory neurological controls (NINDCs), symptomatic controls (SCs). Furthermore, we discuss the application of these control groups in specific study designs, such as for diagnostic biomarker studies, prognostic biomarker studies and therapeutic response studies. Application of these uniform definitions will lead to better comparability of biomarker studies and optimal use of available resources. This will lead to improved quality of CSF biomarker research in MS and related disorders. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Reumatologi och inflammation0 (SwePub)302102 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Rheumatology and Autoimmunity0 (SwePub)302102 hsv//eng |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Neurologi0 (SwePub)302072 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Neurology0 (SwePub)302072 hsv//eng |
700 | 1 | a Menge, T4 aut |
700 | 1 | a Altintas, A4 aut |
700 | 1 | a Alvarez-Cermeno, JC4 aut |
700 | 1 | a Bertolotto, A4 aut |
700 | 1 | a Berven, FS4 aut |
700 | 1 | a Brundin, Lu Karolinska Institutet4 aut |
700 | 1 | a Comabella, M4 aut |
700 | 1 | a Degn, M4 aut |
700 | 1 | a Deisenhammer, F4 aut |
700 | 1 | a Fazekas, F4 aut |
700 | 1 | a Franciotta, D4 aut |
700 | 1 | a Frederiksen, JL4 aut |
700 | 1 | a Galimberti, D4 aut |
700 | 1 | a Gnanapavan, S4 aut |
700 | 1 | a Hegen, H4 aut |
700 | 1 | a Hemmer, B4 aut |
700 | 1 | a Hintzen, R4 aut |
700 | 1 | a Hughes, S4 aut |
700 | 1 | a Iacobaeus, Eu Karolinska Institutet4 aut |
700 | 1 | a Kroksveen, AC4 aut |
700 | 1 | a Kuhle, J4 aut |
700 | 1 | a Richert, J4 aut |
700 | 1 | a Tumani, H4 aut |
700 | 1 | a Villar, LM4 aut |
700 | 1 | a Drulovic, J4 aut |
700 | 1 | a Dujmovic, I4 aut |
700 | 1 | a Khalil, M4 aut |
700 | 1 | a Bartos, A4 aut |
710 | 2 | a Karolinska Institutet4 org |
773 | 0 | t Multiple sclerosis (Houndmills, Basingstoke, England)d : SAGE Publicationsg 19:13, s. 1802-1809q 19:13<1802-1809x 1477-0970x 1352-4585 |
856 | 4 8 | u http://kipublications.ki.se/Default.aspx?queryparsed=id:127920274 |
856 | 4 8 | u https://doi.org/10.1177/1352458513488232 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.